Biotech Values

[DewDiligence]

(ALC/SYK)—Two similar soundbites 10 years apart…

Alcon’s CEO (in current issue of Barron’s):

https://www.barrons.com/articles/why-the-stock-of-eye-care-company-alcon-is-a-buy-51555116958

“People are getting older in the well-reimbursed Western markets, and developing markets are becoming more affluent and prioritizing eye care.”

Former CEO of Stryker (from a 2009 webcast):

#msg-38038167

“In the developed world, people are getting older and sicker, and in the developing world, people are getting richer and fatter.”